This study comprehensively characterized four key NSCLC biomarkers—EGFR, ALK, KRAS, and PDCD1—through an integrated framework combining structural modeling, protein–protein interaction analysis, and transcriptomic validation using public datasets and experimental qPCR in cell lines. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.